Navigation Links
MDS Reports First Quarter 2008 Results
Date:3/6/2008

was partially offset by lower stock-based compensation expense, and spending on the FDA issue in the first quarter of 2007.

We spent $20 million on R&D activities in the first quarter of 2008 compared to $12 million in the first quarter of 2007. The increase in spending is a result of the additional MD spending and higher investment related to the Sciex brand products of MDS Analytical Technologies.

Consolidated depreciation and amortization expense increased $13 million in the first quarter of 2008 compared to the same period last year. The increase is principally related to the amortization of intangible assets associated with the MD acquisition. Capital expenditures for the quarter were $13 million compared to $9 million in the first quarter of 2007.

Reported earnings per share from continuing operations were $0.14 for the quarter, compared to nil in the first quarter of 2007. Adjusted earnings per share from continuing operations for the quarter were $0.05 compared to $0.07 earned in the same period last year. In addition to the adjusting items affecting adjusted EBITDA that were described earlier, adjusting items include a $0.09 reduction in our deferred tax liabilities due to the enactment of income tax rate reductions in Canada. Earnings per share from discontinued operations were nil compared to $0.11 for 2007. Results from discontinued operations include only the results of the diagnostics business that we sold in 2007. Adjusted net income and adjusted earnings per share for the two periods were as follows:

Earnings

Net income per share

---------------------------------------

2008 2007 2008 2007

-------------------------------------------------------------------------

From continuing operations -

<
'/>"/>
SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. American Oriental Bioengineering Reports Fourth Quarter and Full Year 2007 Financial Results
2. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
3. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
4. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
5. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
6. Endocare Reports 2007 Annual and Fourth Quarter Financial Results
7. Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Womens Health Watch
8. CardiacQA Surpasses 20,000 Client Generated Nuclear Cardiology Reports
9. Sunrise Reports Preliminary Selected Financial and Operating Data for Fourth-Quarter 2007
10. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
11. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Motion Graphics ... of a new plugin FCPX3D Confetti designed exclusively for ... exploding transition using confetti particles inside FCPX,” said Christina ... FCPX3D Confetti transition, users will have fun as they ... from one clip to the next with 3D tumbling ...
(Date:3/2/2015)... 02, 2015 Getting customers to discover ... the goal this March as the 31st annual Frozen ... the National Frozen & Refrigerated Foods Association (NFRA) to ... offers more than 20 delicious frozen selections and is ... The tasty frozen options are crafted with simple ingredients, ...
(Date:3/2/2015)... 02, 2015 Cutler Integrative Medicine a ... the root, gives cutting-edge tips to bring about self-renewal. ... renew the body by first cleaning house. According ... “We are all Toxic.” Between environmental toxins like heavy ... greatness, and our high stress levels, we all have ...
(Date:3/2/2015)... York, NY (PRWEB) March 02, 2015 ... long history of catalyzing private sector activities and ... it has recently elected four new members to ... GBCHealth welcomes Dr. Paul Farmer, Chief Strategist and ... Professor at Harvard University; Dr. Huma Abbasi, General ...
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 ... Administration (FDA) warned against the use of power ... and fibroid removal surgeries, insurer UnitedHealthCare is poised ... use of those devices. In a notification sent ... beginning in April, it would require pre-authorization for ...
Breaking Medicine News(10 mins):Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4
... , The Authority offers patients consumer tips and encourages ... improved patient safety , , HARRISBURG, ... Patient Safety Day," Saturday, July 25, which is a national effort ... in their healthcare. , , Pulse ...
... ANAHEIM, Calif., July 24 Elekta CMS Software has ... an advanced IMRT treatment planning solution that combines new levels ... , Monaco with VMAT can optimize ... control needed for complex treatment plans. Reducing planning time and ...
... can be tough, experts admit , FRIDAY, July 24 (HealthDay News) ... not be catching enough zzzs. , Getting a good night,s sleep, ... for shedding baby weight. , One study of new mothers found ... months after giving birth were three times as likely to hold ...
... , DUBLIN, Ohio, July 24 Cardinal ... information officer (CIO), effective Aug. 3. , ... company,s enterprise-wide information technology infrastructure and will work to enhance ... will report to George Barrett, who will become chairman and ...
... , CHICAGO, July 24 International ... designing and manufacturing portable rechargeable systems, today launched ... power supplies. The new 350-watt series, designed for ... an industry-leading converter efficiency of up to 88%. ...
... ... of investment with GBS Venture Partners as AP prepares for market launch of its Navigator™ ... Sydney, ... Pty Ltd (AP), a developer of circulation guidance systems for critically-ill patients, announced today ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Pennsylvania Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution 2Health News:Snoozing May Help Women Shed Baby Weight 2Health News:Snoozing May Help Women Shed Baby Weight 3Health News:Cardinal Health Names Patricia Morrison Chief Information Officer 2Health News:Convection Cooled 350-Watt Open Frame Power Supply Meets Medical and Industrial Safety Standards 2Health News:Applied Physiology Raises $5 Million for Navigator&#8482; Market Launch 2Health News:Applied Physiology Raises $5 Million for Navigator&#8482; Market Launch 3
(Date:3/2/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey ... the fourth quarter and year ended December 31, 2014. ... , Total revenues of $13.7 million in the fourth ... quarter in 2013 , Total revenues of $33.7 million ... 85% over the same period in 2013 , Total ...
(Date:3/2/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... year ended December 31, 2014. Financial highlights for the fourth ... of $5.3 million, or $0.04 per share. This compares to ... million, or $0.19 per share, for the fourth quarter of ... of $75.3 million and a net loss of $68.4 million, ...
(Date:3/2/2015)... , March 2, 2015   Polymedco is committed to ...  During CRC Awareness Month, we are offering all existing ... , Posters – to be hung in ... CRC Patient Brochures with Stand – to be placed ... – to be put on/in patient charts as a ...
Breaking Medicine Technology:IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2
... Genprex, Inc. announced today that it will be presenting at ... San Francisco.   Greg Heinlein , Chief Operating and Financial Officer, ... Forum , on October 25 starting at 11 a.m. PDT in ... be made available on the company,s website under the News & ...
... CINCINNATI, Oct. 20, 2011 Prasco Laboratories , announced ... Eli Lilly and Company (NYSE: LLY ... Tablets and ZYPREXA® ZYDIS (olanzapine) Orally Disintegrating Tablets, in the ... products upon the first ANDA entrant into the market.  Prasco ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2Prasco® Selected as Eli Lilly and Company's Authorized Generics Partner 2
... chloride ring electrodes fit pediatric ... with minicrocodile clip lead wires ... (4 in) long, 0.6 cm ... package contains 50 individually sealed ...
... Made Easy. The new generation FilterWire EZ ... ease of use, providing you with the ... and angioplasty procedures., ,The FilterWire EZ System ... minimal changes to technique. The filter ...
... The Precision PCx point of ... a whole-blood, patient-side testing system for ... use, the system provides fast, accurate ... hospital and laboratory information systems enables ...
... Available in small and large sizes, noise ... easy-to-place, silver/silver chloride disposable tabs. For use ... Dimensions (contact surface): large tabs-2.2 x 2.5 ... cm (0.5 in) square. Each 100-count package ...
Medicine Products: